FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Aspirin/Dipyridamole (Aggrenox) Extended Release Capsules
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Boehringer Ingelheim Pharmaceuticals, Inc. (New 05/26/2020)

Company Contact Information:

Presentation Posting Date Related Information
25mg/200mg capsules (NDC 0597-0001-60) 05/26/2020 Business decision made by the applicant, BIPI. BIPI will no longer be supplying the market with AGGRENOX capsules after June 11, 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English